HEDP en es it fr

HEDP Brand names, HEDP Analogs

HEDP Brand Names Mixture

  • No information avaliable

HEDP Chemical_Formula


HEDP RX_link


HEDP fda sheet

HEDP msds (material safety sheet)

HEDP Synthesis Reference

No information avaliable

HEDP Molecular Weight

391.46 g/mol

HEDP Melting Point

No information avaliable

HEDP H2O Solubility

10 mg/L

HEDP State




HEDP Dosage Forms

Tablets (100 mg)

HEDP Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

HEDP Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

HEDP Absorption

Well absorbed from gastrointestinal tract.

HEDP side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

HEDP Patient Information

HEDP Organisms Affected

Humans and other mammals